Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor: Activation-induced cell death vs passive macrophage-dependent deletion

Journal of Immunology

Volumn 152, Issue 4, 1994, Pages 1597-1608

  Gonzalo, José Angel ^a   Baixeras, Elena ^a   González García, Ana ^a   George Chandy, Annie ^a   Van Rooijen, Nico ^b   Martínez A , Carlos ^a   Kroemer, Guido ^a,c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CLODRONIC ACID; DNA FRAGMENT; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G2A; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LIPOSOME; MIFEPRISTONE; RETINOL; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; IMMUNOMODULATION; LYMPHOCYTE DEPLETION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CELLS, CULTURED; CYTOKINES; ENTEROTOXINS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MIFEPRISTONE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SUPERANTIGENS; T-LYMPHOCYTES; VITAMIN A;

EID: 0028213094     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Urban, J. L., V. Kumar, D. H. Kono, C. Gomez, S. J. Horvath, J. Clayton, D. G. Ando, E. E. Sercarz, and L. Hood. 1988. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577.
2. Acha-Orbea, H., D. J. Mitchell, L. Timmermann, D. C. Wraith, G. S. Tausch, M. K. Waldor, S. S. Zamvil, H. O. McDevitt, and L. Steinman. 1988. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263.
3. Zaller, D. M., G. Osman, O. Kanagawa, and L. Hood. 1990. Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor Vβ specific antibodies. J. Exp. Med. 171: 1943.
4. Rott, O., H. Wekerle, and B. Fleischer. 1992. Protection from experimental allergic encephalomyelitis by application of a bacterial superantigen. Int. Immunol. 4:347.
5. Fukuda, M., F. Hirio, R. Kubo, and M. Hattori. 1989. Monoclonal antibody F23.1 against T-cells bearing V beta 8 TcR elements can prevent the development insulins in NOD mice. Diabetes 38:12.
6. Chiocchia, G., M.-C. Boissier, and C. Fournier. 1991. Therapy against murine collagen-induced arthritis with T cell receptor Vβ-specific antibodies. Eur. J. Immunol. 21:2899.
7. Kim, C., K. A. Siminovitch, and A. Ochi. 1991. Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment. J. Exp. Med. 174:1431.
8. M. de Alborán, I., J. A. Gonzalo, G. Kroemer, E. Leonardo, A. R. Marcos, and C. Martínez-A. 1992. Attenuation of autoimmune disease and lymphocyte accumulation in MRL/lpr mice by treatment with anti-Vβ8 antibodies. Eur. J. Immunol. 22:2153.
9. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705.
10. Staerz, U., H. G. Rammensee, J. D. Benedeto, and M. J. Bevan. 1985. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J. Immunol. 134:3994.
11. Fraser, J. D. 1989. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 339:221.
12. Fleischer, B., and H. Schrezenmeier. 1988. T cell stimulation by staphylococcal enterotocins: clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J. Exp. Med. 167:1697.
13. + T cells. Eur. J. Immunol. 23:523.
14. Ben-Nun, A., and S. Yossefi. 1992. Staphylococcal enterotoxin B as a potent suppressant of T lymphocytes: trace levels suppress T lymphocyte proliferative responses. Eur. J. Immunol. 22:1495.
15. + antigen-presenting cells. Int. Immunol. 4:1381.
16. D'Adamio, L., K. M. Awad, and E. L. Reinherz. 1993. Thymic and peripheral apoptosis of antigen-specific T cells might cooperate in establishing self tolerance. Eur. J. Immunol. 23:747.
17. White, J., A. Herman, A. M. Pullen, R. Kubo, J. W. Kappler, and P. Marrack. 1989. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56:27.
18. D'Adamio, L., L. K. Clayton, K. M. Awad, and E. L. Reinherz. 1992. Negative selection of thymocytes: a novel polymerase chain reaction-based molecular analysis detects requirements for macromolecular synthesis. J. Immunol. 149:3550.
19. + peripheral T cells responding to staphylococcal enterotoxin B in vivo. Eur. J. Immunol. 21:1963.
20. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:91.
21. + cells to bacterial superantigens. Eur. J. Immunol. 22:1935.
22. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349:245.
23. + T cells in Staphylocccus enterotoxin B-primed mice. J. Exp. Med. 172: 1065.
24. Lee, W. T., and E. S. Vitetta. 1992. Memory T cells are anergic to the superantigen staphylococcal enterotoxin B. J. Exp. Med. 176:575.
25. Ochi, A., K. Yuh, and K. Migita. 1993. Not every superantigen induces tolerance in vivo. Semin. Immunol. 5:57.
26. Meuer, S. C., J. C. Hodgdon, R. E. Hussey, J. P. Protentis, S. F. Schlossman, and E. L. Reinherz. 1983. Antigen-like effects of monoclonal antibodies directed at receptors of human T cell clones. J. Exp. Med. 158:388.
27. Kappler, J., R. Kubo, V. Haskins, J. White, and P. Marrack. 1983. The mouse T cell receptor: comparison of MHC-restricted receptors on two T cell hybridomas. Cell 34:727.
28. β11-bearing cells. J. Exp. Med. 169:1405.
29. Alcorn, J. M., J. Fierer, and M. Chojker. 1992. The acute-phase response protects mice from D-galactosamine sensitization to endotoxin and tumor necrosis factor. Hepatology 15:122.
30. Huesmann, M., B. Scott, P. Kisielow, and H. von Boehmer. 1991. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell 66:533.
31. Van Rooijen, N. 1989. The liposome-mediated macrophage 'suicide' technique. J. Immunol. Methods 124:1.
32. Kanagawa, O. 1989. In vivo T cell tumor therapy with monoclonal antibody directed to the Vβ chain of T cell antigen receptor. J. Exp. Med. 170:1513.
33. Andreu-Sánchez, J. L., I. Moreno de Alborán, M. A. R. Marcos, A. Sánchez-Movilla, C. Martínez-A, and G. Kroemer. 1991. IL-2 abrogates the non-responsive state of T cells expressing a forbidden TCR repertoire and induces autoimmune disease in neonatally thymectomized mice. J. Exp. Med. 173:1323.
34. Gonzalo, J. A., I. Moreno de Alborán, J. E. Alés-Martínez, C. Martínez-A., and G. Kroemer. 1992. Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin 2 pathway. Eur. J. Immunol. 22:1007.
35. Sambrook, J., E. R. Fritsch, and T. Maniatis. 1989. Molecular Cloning - A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
36. Wahl, S., T. Miethke, K. Heeg, and H. Wagner. 1993. Clonal deletion as direct consequence of an in vivo T cell response to bacterial superantigen. Eur. J. Immunol. 23:1197.
37. Iwata, M., M. Mukai, Y. Nakai, and R. Iseki. 1992. Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes. J. Immunol. 149:3202.
38. Yang, Y., M. S. Vacchio, and J. D. Ashwell. 1993. 9-cis retinoic acid inhibits activation-driven T cell apoptosis: Implications for retinoid X receptor involvement in thymocyte development. Proc. Natl. Acad. Sci. USA 90:6170.
39. Gonzalo, J. A., A. González-García, C. Martínez-A., and G. Kroemer. 1993. Glucocorticoid-mediated control of the clonal deletion and activation of peripheral T cells in vivo. J. Exp. Med. 177:1239.
40. Stockinger, B., C. F. Grant, and B. Hausmann. 1993. Localization of self antigen: implications for antigen presentation and induction of tolerance. Eur. J. Immunol. 23:6.
41. van Rooijen, N., N. Kors, and G. Kraal. 1989. Macrophage subset repopulation in the spleen: differential kinetics after liposome-mediated elimination. J. Leukocyte Biol. 45:97.
42. Nakashima, M., K. Mori, K. Maeda, H. Kishi, K. Hirata, M. Kawabuchi, and T. Watanabe. 1990. Selective elimination of double-positive immature thymocytes by a thymic epithelial cell line. Eur. J. Immunol. 20:47.
43. Bhardwaj, N., S. M. Friedman, B. C. Cole, and A. J. Nisanian. 1992. Dentritic cells are potent antigen-presenting cells for microbial superantigens. J. Exp. Med. 175:267.
44. Tomonari, K. 1990. Tolerance in vivo and in vitro. Immunol. Rev. 116:139.
45. Besedovsky, H. O., A. del Rey, I. Klusman, H. Furukawa, G. Monge-Arditi, and A. Kabiersch. 1991. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J. Steroid Biochem. Mol. Biol. 40:613.
46. Wick, G., Y. Hus, S. Schwartz, and G. Kroemer. 1993. The immunehypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocrine Rev. 14:539.
47. Lehmann, V., M. A. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165:657.
48. Evans, G. F., and S. H. Zuckerman. 1991. Glucocorticoid-dependent and -independent mechanisms involved in lipopolysaccharide tolerance. Eur. J. Immunol. 21:1973.
49. Wallach, D., H. Holtmann, H. Engelmann, and Y. Nophar. 1988. Sensitization and desensitization to lethal effects of tumor necrosis factor α and IL-1. J. Immunol. 140:2994.
50. Takimoto, H., Y. Yoshikai, K. Kisihara, G. Matsuzaki, H. Kuga, T. Otani, and K. Nomoto. 1990. Stimulation of all T cells bearing Vβ1, Vβ3, Vβ11 and Vβ12 by staphylococcal enterotoxin A. Eur. J. Immunol. 20:617.
51. Miethke, T., C. Wahl, K. Heeg, and H. Wagner. 1993. Acquired resistance to superantigen-induced T cell shock. Vβ selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity. J. Immunol. 150:3776.
52. Vassalli, P. 1992. The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol. 10:411.
53. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 229:869.
54. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, and G. C. Kuo. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330:662.
55. Waage, A., and T. Espevik. 1988. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice. J. Exp. Med. 167:1987.
56. Doherty, G. M., J. R. Lange, H. N. Langstein, H. R. Alexander, C. M. Buresh, and J. A. Norton. 1992. Evidence of IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor. J. Immunol. 149:1666.
57. Gérard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxinemia. J. Exp. Med. 177:547.
58. Howard, D., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxinemia. J. Exp. Med. 177: 1205.
59. Vanier, L. E., and G. J. Prud'homme. 1992. Cyclosporin A markedly enhances superantigen-induced peripheral T cell deletion and inhibits anergy induction. J. Exp. Med. 176:37.
60. Lussow, A. R., T. Crompton, O. Karapetian, and H. R. MacDonald. 1993. Peripheral clonal deletion of superantigen-reactive T cells is enhanced by cortisone. Eur. J. Immunol. 23:578.
61. Garbe, A., J. Buck, and U. Hümmerling. 1992. Retinoids are important cofactors in T cell activation. J Exp. Med. 176:109.
62. + thymocytes in vivo by anti-CD3 or 5′-(N-ethyl)-cabox-amido-adenosine is blocked by glucocorticoid receptor antagonist RU-486. Eur. J. Immunol. 23:1246.
63. - T cells. Int. Immunol. 4:599.
64. Brown, D. G., X. M. Sun, and G. M. Cohen. 1993. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem. 268:3037.
65. Savill, J. S., P. M. Henson, and C. Haslett. 1989. Phagocytosis of aged human neutrophils by macrophages is mediated by a novel "charge-sensitive" recognition mechanism. J. Clin. Invest. 84: 1518.
66. Fadok, V. A., D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson. 1992. Exposure of phophatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207.
67. Savill, J., V. Fadok, P. Henson, and C. Haslett. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14:131.
68. Dohlsten, M., G. Hedlund, and T. Kalland. 1991. Staphylococcal-enterotoxin-dependent cell-mediated cytotoxicity. Immunol. Today 12:147.
69. Savill, J., I. Dransfield, N. Hogg, and C. Haslett. 1990. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343:170.
70. Golstein, P., D. M. Ojcius, and J. D.-E. Young. 1991. Cell death mechanisms and the immune system, Immunol. Rev. 121:29.
71. Waldmann, H. 1989. Manipulation of T-cell response with monoclonal antibodies. Annu. Rev. Immunol. 7:407.
72. Cohen, I. J., R. C. Duke, V. A. Fadok, and K. S. Sellins. 1992. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10:267.
73. Gonzalo, J. A., C. Martínez-A., and G. Kroemer. 1993. A single injection of Staphylococcus aureus enterotoxin B (SEB) inhibits autoimmunity of MRL/Mp-lpr/lpr mice. J. Immunol. 150:78A.